ELLEN RATAY: Open Payments
NPI 1114260270 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 45 payments from 15 companies in 2025. Trend: 2023 $705 · 2024 $1,442 · 2025 $992
Food & beverage: $992
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $244 |
| ABBVIE INC. | 12 | $243 |
| QOL Medical, LLC | 4 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Braintree Laboratories, Inc. | 3 | $49 |
| Ardelyx, Inc. | 2 | $47 |
| Madrigal Pharmaceuticals | 2 | $41 |
| Celltrion USA Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $30 |
Products named: TREMFYA, SKYRIZI, Sucraid, DUPIXENT, EOHILIA, IBSRELA, LINZESS, REZDIFFRA.
Industry payments across OH — which companies pay providers there.
